BIOTECH

12 of 12 resultsNews

  • Clinical Data to present at biotech conference

    Clinical Data to present at biotech conference

    CLINICAL Data has announced it will present at the 2009 Future Leaders in the Biotech Industry Conference held on 2 April 2009.

    27/03/2009

  • Sartorius Stedim Biotech and SAFC join forces

    SARTORIUS Stedim Biotech and SAFC Biosciences have announced the signing of a global partnership agreement which combines Sartorius Stedim Biotech's (SSB) filtration and liquid handling systems with SAFC Biosciences' development and manufacturing of cell culture media and downstream purification products.

    24/07/2009

  • Biotechnology conference in Sydney

    AS PART of the Business Club Australia’s (BCA) Bledisloe Cup events program, seven Biotech international representatives have arrived in Sydney to speak at a Life Science seminar today, Friday 21 August 2009.

    21/08/2009

  • Merck announces Merck Serono Ventures

    Merck announces Merck Serono Ventures

    MERCK has announced the formation of Merck Serono Ventures, a corporate venture capital fund to incest in emerging biotechnology companies.

    26/03/2009

  • PerkinElmer opens second COE in Singapore

    PerkinElmer opens second COE in Singapore

    PERKINELMER has announced the inauguration of a Centre of Excellence (COE) in Singapore.

    05/03/2009

  • A closer look at Coral: Genetic sequencing in Australian aquatic animals

    RESEARCHERS from the Australian Genome Research Facility (AGRF) and ARC Centre of Excellence for Coral Reef Studies (CoECRS) are set to being sequencing the genome of an antipodean coral, marking the first time an aquatic animal will be fully sequenced in this country.

    07/08/2009

  • Merck and Millipore announce transaction

    Merck and Millipore have entered into a definitive agreement under which Merck will acquire all outstanding shares of common stock of Millipore for US$107 per share in cash, or a total transaction value, including net debt, of approximately US$7.2 billion.

    12/03/2010

  • Colorectal cancer drugs altered for KRAS mutation

    PRODUCT labels on the class of drugs known as anti-EGFR monoclonal antibodies, specifically cetuximab (Erbitux) and panitumumab (Vectibix) have just been changed to no longer be recommended for the treatment colorectal cancers in patients with mutation KRAS.

    04/08/2009

  • Sipping vaccines for stomach bugs

    The Australian scientist Dr Barry Marshall, who discovered the bacterium Helicobacter pylori was responsible for causing stomach ulcers, is now working towards a vaccine against H. pylori that can be eaten rather than injected.

    15/12/2009

  • Fluidigm's microfluidic system used to validate cattle tests

    Fluidigm's microfluidic system used to validate cattle tests

    The US Department of Agriculture's Agricultural Research Service (ARS) has purchased a Fluidigm microfluidic-based EP1 System. They will use the system to help develop and validate focused 96- and 384-SNP (single-nucleotide polymorphism) panels for testing the health and quality of America's dairy and beef cattle.

    11/02/2010

  • Biosignal sells biofilm IP to Commonwealth Biotechnologies

    BIOSIGNAL has signed an agreement to sell the Biosignal biofilm intellectual property to Commonwealth Biotechnologies.

    14/07/2009

  • UQ study finds accountants kill innovation for biotechs

    Australian biotechnology start-ups are more successful at developing their product pipelines when they ignore the accountant and rely on market judgement, claims a UQ research team.

    12/03/2010

 

1 of 1 resultsEvents

 

4 of 4 resultsProducts

    • Viral cleaning solution launched

      Viral cleaning solution launched

      MILLIPORE has launched a virus clearance solution designed for use on biotech products derived from recombinant cell lines or human plasma.

    • Float-A-Lyzer G2 for high sample recovery

      Float-A-Lyzer G2 for high sample recovery

      Spectrum Laboratories introduces the Spectra/Por Float-A-Lyzer G2, the next generation of ready-to-use laboratory dialysis devices featuring an ultra-pure biotech cellulose ester (CE) membrane.

    • Sigma-Aldrich expands its stem cell portfolio

      Sigma-Aldrich has entered into an exclusive worldwide agreement with Stemgent to distribute Stemgent’s lentivirus-based gene delivery products for the generation of induced pluripotent stem (iPS) cells.

    • Production scale freeze drying hits the benchmark

      Production scale freeze drying hits the benchmark

      The Virtis Benchmark Series Lyophilizer from SP Scientific is said to provide reproducibly process a wide range of pharmaceutical and biotech products.

     

    1 of 1 resultsCompanies

     
    to get Life Science Lab
    delivered to your inbox

    Latest from Twitter

      Getting your tweets...